NIKKEI 225
38,627.81 -319.12 (-0.82%) HANG SENG
19,285.90 +65.28 (+0.34%) CRUDE OIL
79.06 -0.20 (-0.25%) GOLD FUTURES
2,417.40 -8.50 (-0.35%) DOW
39,872.99 +66.22 (+0.17%) Bitcoin GBP
54,966.22 -857.15 (-1.54%)
MDT Jun 2024 47.500 call
| Previous close | 25.00 |
| Open | 25.00 |
| Bid | 31.05 |
| Ask | 32.90 |
| Strike | 47.50 |
| Expiry date | 2024-06-21 |
| Day's range | 25.00 - 25.00 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
BenzingaMedtronic's Heart Catheter Achieves Safety And Efficacy Goals In Patients With Irregular Heartbeat
On Friday, Medtronic plc (NYSE:MDT) released results from the SPHERE Per-AF study comparing Sphere-9 to the conventional Thermocool SmartTouch SF radiofrequency ablation catheter with the Carto 3 System. The findings were presented as late-breaking clinical data at the Heart Rhythm Society 2024 Annual Meeting and published in Nature Medicine. The study demonstrated the safety and efficacy of the Affera Mapping and Ablation System with Sphere-9 Catheter, an all-in-one pulsed field (PF) and radiof
PR NewswireMiniMed™ 780G system recognized among Fast Company's 2024 World Changing Ideas
Fast Company announced that the Medtronic MiniMed™ 780G automated insulin delivery system has been recognized in the Best World-Changing Idea, North America category as part of the 2024 World Changing Ideas Awards.
ZacksMedtronic (MDT) Reports Favorable SPHERE Per-AF Trial Outcome
Medtronic's (MDT) Affera Mapping and Ablation System with Sphere-9 Catheter achieves endpoints for safety and efficacy for the treatment of AFib.
